Recruiting

Mental Health TreatmentsRetrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments

Sponsor:

Neuronetics

Code:

NCT06997549

Conditions

Depression

OCD

Anxiety Depression

Eligibility Criteria

Sex: All

Age: 5 - 70+

Healthy Volunteers: Not accepted

Interventions

Patients treated with NeuroStar TMS

Patients treated with Esketamine

Study Details

Brief summary:

The study involves multiple retrospective analyses to understand the utilization of mental health treatments provided at Greenbrook and their effectiveness

Conditions

Depression

OCD

Anxiety Depression

Study ID

NCT06997549

Start date

May 15, 2025

Status verified date

Apr, 2026

Completion date

Dec, 2035

Anticipated

Primary completion date

Dec, 2035

Anticipated

Eligibility Criteria

Sex: All

Age: 5 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

Male or female reported in database and not an invalid entry
Age reported and not an invalid entry
Treatment date in 2011 or later.

Exclusion Criteria:

• Incomplete information on treatment parameters

Study Design

Enrollment

12000 participants

Anticipated

Interventions and Outcome Measures

Interventions

Patients treated with NeuroStar TMS

non-invasive brain stimulation device

Patients treated with Esketamine

nasal spray for treating depression

Primary outcome measure

change in clinical outcome scores from baseline to post treatment [ Time Frame: 8 weeks ]

Central Contacts and Locations

Central contacts

Neha Goyal

7635281599 neha.goyal@neurostar.com

Eleanor Cole, PhD

415-724-7960 Eleanor.cole@neurostar.com

Locations

Neuronetics

Recruiting

Malvern, Pennsylvania, United States, 19355

More Information

Sponsor

Neuronetics

Last update posted

Apr 9, 2026

Last verified

Apr, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Neuronetics on 2026-04-09.